News | PACS | November 19, 2019

Infinitt to showcase Infinitt PACS 7.0 at RSNA19

Infinitt PACS 7.0 is a faster, more powerful viewer that was built from the ground up to support AI for image analysis and for operational/ workflow improvements in radiology

November 19, 2019 — Infinitt North America will be highlighting a next generation, artificial intelligence (AI)-empowered picture archiving and communication system (PACS) viewer at RSNA 2019. The annual meeting of the Radiological Society of North America (RSNA) will convene at McCormick Place in Chicago Dec. 1-5, 2019.

Infinitt PACS 7.0 is a faster, more powerful viewer that was built from the ground up to support AI for image analysis and for operational/ workflow improvements in radiology. In addition, Infinitt integrates with a number of AI solutions that can be accessed through Infinitt PACS, and offers the Envoy AI platform for broad-based access to third-party medical imaging algorithms. Infinitt works in close partnership with TeraRecon, Vuno, Lunit and many other companies globally to provide easy access to their AI algorithms and tools.

Infinitt PACS also includes an AI-empowered Dynamic Worklist feature that uses an intelligent task engine to analyze your incoming tasks, identify high priority cases and push them to user worklists according to priority and reading status. It will sort tasks into customizable folders, accommodating your reading style while allowing you to monitor your reading status relative to SLAs. A notification feature provides alerts and reminders for scheduled events, incoming messages, and more.

In addition, embedded AI image analysis brings you to the most important part of the image as quickly as possible. It will detect anomalies and regions of interest, and can save critical time when identifying life threatening abnormalities. In urgent cases, faster response times can have a significant impact on patient outcomes.

As part of a broader enterprise imaging (EI) solution, INFINITT offers a vendor-neutral archiving (VNA) platform, a Enterprise Viewer, Infinitt Cardiology Suite, Infinitt Mammo PACS, Infinitt Digital Pathology Solution, Infinitt Dental PACS, seamless integration with TeraRecon Advanced Visualization packages, and more.

Infinitt PACS has been ranked No. 1 Category Leader in the 2019 Best in KLAS Awards: Software and Services report for PACS Community Hospital and PACS Imaging Centers/Ambulatory categories. Infinitt is widely recognized for its commitment to customer support, responsive service and attention to detail. Infinitt PACS has won Category Leader designations in the Best in KLAS: Software and Services report twelve times since 2009.

For more information: www.infinittna.com

Related Content

Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in ...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer | October 21, 2020
October 21, 2020 — Quantib, a market leader in...
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...